logo
logo

Vivid Dx Appoints John Sperzel As Chief Executive Officer

Jul 16, 2025•17 days ago

Position

Chief Executive Officer

Company

Vivid Dx

John Sperzel
OxfordHealth DiagnosticsBiotechnologyHealth Care

Description

Vivid Dx announces the appointment of John Sperzel as Chief Executive Officer, effective immediately. With over three decades of leadership in the diagnostics sector, Sperzel is expected to guide the company towards clinical validation and commercial success.

Company Information

Company

Vivid Dx

Location

Oxford, England, United Kingdom

About

Vivid Dx is a precision diagnostics company transforming pathogen detection and antimicrobial resistance testing. The company is developing a next-generation platform to deliver broad pathogen ID in 30 minutes and antibiotic susceptibility testing in 3 hours directly from blood. A spin-out from the University of Oxford, Vivid Dx aims to redefine the speed and accuracy of infectious disease diagnostics.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months